Nanosphere Health Sciences Inc. is Nominated for NCIA’s Excellence in Technology Award

Screen Shot 2018 01 11 at 2.27.21 PM
Screen Shot 2018 01 11 at 2.27.21 PM
DENVER – January 11, 2018 – NanoSphere Health Sciences Inc. (CSE: NSHS, “NanoSphere”) is pleased to announce that it has been nominated for the National Cannabis Industry Association’s Excellence in Technology Award in Infused Products and Extraction. This award goes to a NCIA member who has developed new technology that will have a lasting impact on the industry. Also, effective today, NanoSphere’s OTC ticker code NSHSF has been approved for use.
“It comes as no surprise to us that our technology is being recognized for its market disruption,” said Dr. Richard Kaufman, Chief Science Officer at NanoSphere. “We are proud of our achievements so far in the nanoparticle delivery space and look forward to advancing our technology with new applications and new markets.”
NanoSphere is commercializing its disruptive, next-generation nanoparticle cannabis delivery system platforms under the brand Evolve Formulas. In July 2017, Evolve launched its acclaimed NanoSerum™ product for the recreational and medical cannabis markets in Colorado. NanoSerum™ which has made major market inroads in less than six months of sale, is the first clinically tested transdermal cannabis product to relieve pain in minutes.
NanoSphere Chairman and CEO Robert Sutton added, “As our company is opened to the investor marketplace, more and more consumers will discover our technology. The re-order rate of our NanoSerum product is a testament to its quality and effectiveness.”
The award-winning Evolve is available in over 70 accounts throughout Colorado. NanoSphere expects to expand its fast-growing network with manufacturers and operators in several states to license our technology and bring the Evolve brand to new U.S. markets, and to build on that success by further introducing new product applications. Each product application will deliver a unique pharmacokinetic and pharmacodynamic profile of cannabinoid activity
and therapeutic applications.